Back to Markets
CLCelldex Therapeutics Inc

Celldex Therapeutics Inc

CLDXNASDAQ NMS - GLOBAL MARKET
Health CareBiotechnology

$31.43

-0.270000 (-0.85%)

As of 05/29/26 EDT · USD

Compare
Low: $19.25Current: $31.43High: $35.79

Key Statistics

Open

$31.79

Day High

$32.00

Day Low

$31.09

Prev. Close

$31.70

VolumeShares traded today.

429.83K

Avg. VolumeAverage daily volume.

Market CapTotal value of all shares = price × shares outstanding.

$2.47B

P/E (TTM)Price-to-Earnings: share price ÷ earnings per share over the last 12 months. Lower can mean cheaper; very high can mean growth expectations.

-7.37

Forward P/EP/E based on forecast next-year earnings.

P/B RatioPrice-to-Book: share price ÷ book value per share.

52W HighHighest price over the past 52 weeks.

$35.79

52W LowLowest price over the past 52 weeks.

$19.25

50D MAAverage closing price over the last 50 trading days.

$32.23

200D MAAverage closing price over the last 200 trading days.

$27.48

Dividend YieldAnnual dividend ÷ share price, as a %.

BetaVolatility vs the market. >1 = more volatile than the S&P 500.

Performance

1W

+2.8%

1M

-2.2%

6M

+18.9%

YTD

+16.4%

1Y

+57.4%

About

Glembatumumab vedotin is an antibody-drug conjugate (ADC) that targets cancer cells expressing transmembrane glycoprotein NMB (GPNMB).

celldex.com/

Company Facts

SectorHealth Care
IndustryBiotechnology
ExchangeNASDAQ NMS - GLOBAL MARKET
CurrencyUSD

Sentiment

Latest News

Social Noise

Price Alerts

Loading…

Trade CLDX

Brokers available in your region (US)

Affiliate links — we may earn a commission. CFDs are risky.